West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$318.02 USD
+0.10 (0.03%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $318.06 +0.04 (0.01%) 6:40 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
WST 318.02 +0.10(0.03%)
Will WST be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
4 Stocks to Buy Amid Dental Supplies Industry Challenges
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
Other News for WST
West Pharmaceutical Services Takes Over #321 Spot From Estee Lauder
Video: S&P 500 Analyst Moves: WST
West Pharmaceutical Services Takes Over #90 Spot From PG&E
West to Host Second-Quarter 2024 Conference Call
Buy Rating for West Pharmaceutical Services: Market Leadership and Growth Catalysts in Pharmaceutical Packaging